Diflucan

Страна: Армения

Язык: английский

Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Активный ингредиент:

fluconazole

Доступна с:

Fareva Amboise

ИНН (Международная Имя):

fluconazole

дозировка:

2mg/ml

Фармацевтическая форма:

solution for i/v infusion

Тип рецепта:

Prescription

Характеристики продукта

SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAMEOF THE MEDICINAL PRODUCT
DIFLUCAN
®
50 mg, capsules
DIFLUCAN
®
150 mg, capsules
DIFLUCAN
®
2 mg/ml, solution for infusion
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substance: fluconazole DIFLUCAN capsules 50 mg and 150 mg
contains active ingredient
respectively 50 mg and 150 mg. The solution for infusion represents 2
mg/ml in a saline solution.
For the full list of excipients, please refer to section 6.1.
3.
PHARMACEUTICAL FORM
Capsule, solution for intravenous infusion.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Therapy may be instituted before the results of the cultures and other
laboratory studies are known;
however, once these results become available, anti-infective therapy
should be adjusted accordingly.
1.
Cryptococcosis, including cryptococcal meningitis and infections of
other sites (e.g., pulmonary,
cutaneous).
Normal
hosts
and
patients
with
AIDS,
organ
transplants
or
other
causes
of
immunosuppression may be treated. Fluconazole can be used as
maintenance therapy to prevent relapse
of cryptococcal disease in patients with AIDS.
2.
Systemic candidiasis, including candidemia, disseminated candidiasis
and other forms of invasive
candidal infection. These include infections of the peritoneum,
endocardium, eye, and pulmonary and
urinary
tracts.
Patients
with
malignancy,
in
intensive
care
units,
receiving
cytotoxic
or
immunosuppressive therapy, or with other factors predisposing to
candidal infection may be treated.
3. Mucosal candidiasis. These include oropharyngeal, esophageal,
non-invasive bronchopulmonary
infections, candiduria, mucocutaneous and chronic oral atrophic
candidiasis (denture sore mouth).
Normal hosts and patients with compromised immune function may be
treated. Prevention of
relapse of oropharyngeal candidiasis in patients with AIDS.
4.
Genital
candidiasis.
Vaginal
candidiasis,
acute
or
recurrent;
and
prophylaxis
to
reduce
the
incidence of recurrent vaginal candidiasis (3 or more episodes a
year).Candidal balanitis.
5.
Preventio